Twistle Acquisition: Key Details, Impact, and What Comes Next

Health Catalyst's acquisition of Twistle marks a significant step in the healthcare industry. By integrating Twistle's patient engagement technology with Health Catalyst's data analytics platform, the merger aims to enhance population health management. This strategic move underscores the growing importance of data-driven solutions in supporting healthcare organizations transitioning to value-based care models.

What Is Twistle?

Founded in 2011, Twistle offers a patient engagement software platform that automates multi-channel communication between care teams and patients. Its core services include personalized messaging, AI-optimized communication, and seamless integration with existing IT ecosystems like EHRs and CRMs. Twistle stands out in the market by improving patient outcomes, increasing staff productivity through proactive alerts, and demonstrating a proven impact on reducing hospital readmissions, length of stay, and no-show rates.

Who Acquired Twistle?

Health Catalyst is a prominent provider of data and analytics technology and services in the healthcare sector. The company offers a wide range of solutions, including Ignite Data and Analytics, Population Health Management, and Clinical Quality Improvement. Health Catalyst is recognized for its significant influence, demonstrated by $2.2 billion in validated measurable improvements across numerous customer success stories. The introduction of Health Catalyst Ignite™ highlights its innovative approach to transforming healthcare data into actionable insights.

When Was Twistle Acquired?

Health Catalyst announced its agreement to acquire Twistle on June 24, 2021, with the transaction expected to close in early Q3 2021. This acquisition aligns with the broader industry trend of healthcare organizations transitioning to value-based care models. By integrating Twistle's patient engagement technology, Health Catalyst aims to enhance its population health capabilities, reflecting a strategic move to support data-driven, patient-centered care solutions.

Why Was Twistle Acquired?

• Market Expansion: The acquisition of Twistle enables Health Catalyst to expand its market presence by enhancing its population health capabilities. This strategic move allows Health Catalyst to offer a comprehensive solution that integrates patient engagement with data analytics, addressing the needs of healthcare organizations transitioning to value-based care.
• Technology Integration: By integrating Twistle's patient engagement platform with Health Catalyst's cloud-based data platform, DOS™, the company can enable richer data-driven patient interactions. This integration supports Health Catalyst's clinical, quality, and Life Sciences solutions, enhancing overall clinical workflows and patient communication channels.
• Competitive Advantage: The merger strengthens Health Catalyst's competitive position by combining advanced patient engagement technology with robust data analytics. This synergy is expected to drive better patient outcomes, reduce healthcare costs, and improve patient engagement, providing a significant edge in the healthcare technology market.

Acquisition Terms

• Acquisition Price: The acquisition price is approximately $104.5 million, with an additional potential earn-out of up to $65 million based on performance targets.
• Payment Method: Health Catalyst plans to pay $57.5 million in cash and $47 million in company stock as part of the deal.
• Key Conditions or Agreements: The transaction is subject to customary closing conditions and is expected to close in early Q3 2021. The potential earn-out of up to $65 million is based on performance targets.

Impact on Twistle

The acquisition of Twistle by Health Catalyst has led to significant changes in operations and management. Twistle's patient engagement platform is now integrated with Health Catalyst's population health offerings, enhancing the overall capabilities of both companies. This integration aims to create a more comprehensive solution for healthcare providers, combining Twistle's automated communication technology with Health Catalyst's data analytics platform. The transaction, funded through a mix of cash and stock, is expected to close in early Q3 2021, subject to customary closing conditions.

In terms of product offerings, the merger has enriched Health Catalyst's suite of solutions, particularly in patient engagement and population health management. Twistle's technology, now part of Health Catalyst's cloud-based data platform, DOS™, enables more intelligent and individualized patient outreach. Employee reactions have not been explicitly documented, but executive statements suggest a positive outlook on the integration. Customers, including Aaron Martin from Providence Ventures, have expressed optimism about the combined technologies' potential to accelerate innovation and improve care delivery.

For founders considering business transitions, tools like Sunset can assist in managing such processes compliantly, ensuring a smooth and efficient transition.